nifedipine has been researched along with Schizophrenia in 10 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 9.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 9.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 5.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| " Fifty-one patients diagnosed with paranoid schizophrenia received haloperidol in combination with nifedipine (25 patients) or haloperidol only (26 patients) during 26 weeks." | 5.13 | [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics]. ( Popov, MIu, 2008) |
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 5.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "We examined whether nifedipine, a calcium channel antagonist, added to a stable regimen of neuroleptic medication would affect cognition in patients with chronic schizophrenia or schizoaffective disorder who had tardive dyskinesia." | 5.08 | Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia. ( Deutsch, SI; Fay-McCarthy, M; Kendrick, K; Rosse, RB; Schwartz, BL, 1997) |
| "In an open label study, two fixed doses of nifedipine (30 mg and 60 mg daily) were added to the usual antipsychotic drug treatments of 10 patients suffering from chronic schizophrenia." | 5.07 | Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. ( Eyles, D; Pond, SM; Stedman, TJ; Welham, JL; Whiteford, HA, 1991) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 5.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 1.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popov, MIu | 1 |
| Dzhuga, NP | 1 |
| Kozlovskiĭ, VL | 1 |
| Solís-Chagoyán, H | 1 |
| Calixto, E | 1 |
| Figueroa, A | 1 |
| Montaño, LM | 1 |
| Berlanga, C | 1 |
| Rodríguez-Verdugo, MS | 1 |
| Romo, F | 1 |
| Jiménez, M | 1 |
| Gurrola, CZ | 1 |
| Riquelme, A | 1 |
| Benítez-King, G | 1 |
| Yamada, K | 2 |
| Kanba, S | 2 |
| Ashikari, I | 2 |
| Ohnishi, K | 1 |
| Yagi, G | 2 |
| Asai, M | 2 |
| Onishi, K | 1 |
| Schwartz, BL | 1 |
| Fay-McCarthy, M | 1 |
| Kendrick, K | 1 |
| Rosse, RB | 1 |
| Deutsch, SI | 1 |
| Stedman, TJ | 1 |
| Whiteford, HA | 1 |
| Eyles, D | 1 |
| Welham, JL | 1 |
| Pond, SM | 1 |
| Suddath, RL | 1 |
| Straw, GM | 1 |
| Freed, WJ | 1 |
| Bigelow, LB | 1 |
| Kirch, DG | 1 |
| Wyatt, RJ | 1 |
| Duncan, E | 1 |
| Adler, L | 1 |
| Angrist, B | 1 |
| Rotrosen, J | 1 |
| Kramer, MS | 1 |
| DeMaria, P | 1 |
| Morrow, R | 1 |
| DiJohnson, C | 1 |
| Sheves, P | 1 |
6 trials available for nifedipine and Schizophrenia
| Article | Year |
|---|---|
[The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Female; Haloperidol; Humans; Male; Nifedipine; | 2008 |
Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off.
Topics: Adult; Aged; Calcium Channel Blockers; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dys | 1996 |
Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia.
Topics: Aged; Calcium Channel Blockers; Cognition; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug | 1997 |
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperido | 1991 |
A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Benztropine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Hum | 1991 |
Nifedipine in the treatment of tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Neurologic Examina | 1990 |
4 other studies available for nifedipine and Schizophrenia
| Article | Year |
|---|---|
[Effect of nifedipine on the effectiveness of antipsychotic therapy in schizophrenia].
Topics: Adult; Antipsychotic Agents; Calcium Channel Blockers; Cognition; Dibenzothiazepines; Dose-Response | 2009 |
Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder.
Topics: Biomarkers; Bipolar Disorder; Calcium; Calcium Channels, L-Type; Cells, Cultured; Humans; Microtubul | 2013 |
Effectiveness of nilvadipine in two cases of chronic schizophrenia.
Topics: Calcium Channel Blockers; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Nife | 1995 |
Nifedipine in neuroleptic-refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Resistance; Humans; Male; Middle Aged; Nifedipine; Psychiatric Sta | 1987 |